Loading...
RCT
Published: Apr 2013
ACE Report #10365
Ace Report Cover Cannabis

Cannabis oralmucosal spray does not significantly improve neuropathic pain from multiple sclerosis


Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis

J Neurol. 2013 Apr;260(4):984-97. doi: 10.1007/s00415-012-6739-4

Contributing Authors: S Ratcliffe W Notcutt RM Langford J Mares A Novotna M Vachova I Novakova

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.